CLOSE X
GO

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)

very highequitypharma & health care
38.82 -0.22(-0.56%) NAV as on 20 Dec 2024
3.74 % 1 M
49.14 % 1 Y
25.86 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.However there can be no assurance that the investment objectives of the scheme will be realized.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

1.92

As on 30 Nov, 2024
age-icon Age :

6 yrs 5 m

Since 13 07 ,2018
exit_load Exit Load :

1%

aum AUM :

5,044.63 Crs

lock_in Lock-in :

1% on or before 15D, Nil after 15D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

6.08

Min_Investment Min. Investment :

SIP 100 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Dharmesh Kakkad

LATEST ASSET & PORTFOLIO ALLOCATION

as on Nov 30 ,2024
Others 2.73 %
Equity 97.27 %

TOP HOLDINGS

Sun Pharmaceutical Industries...13.77 %
Dr. Reddy's Laboratories Ltd.8.48 %
Cipla Ltd.7.94 %
Aurobindo Pharma Ltd.5.04 %
Gland Pharma Ltd.4.38 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs75.75
Hospital & Healthcare Services13.30
Business Support4.70
Insurance2.40
Chemicals1.12
See All Sectors

5-YEARS HISTORY

Financial Year2019-20202020-20212021-20222022-20232023-2024
NAV in Rs (as on 31-Mar-2024)9.5417.3519.6918.6430.20
Net Assets(Rs Crores) (as on 31-Mar-2024) 1073.47 2213.63 2500.42 2594.59 3772.32
Scheme Returns(%)(Absolute)-6.3883.7912.51-5.3861.15
B'mark Returns(%)(Absolute)NANANANANA
Category Rank15/7519/7547/7563/7612/90

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity38.82-0.22(-0.56%)NAV As on 20 Dec, 202413-Jul-2018Inception Date5,044.63AUM In Cr.49.14%1Y25.86%3Y30.25%5Y23.43%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity425.34-3.87(-0.90%)NAV As on 20 Dec, 202414-Jul-1999Inception Date3,459.68AUM In Cr.44.04%1Y25.17%3Y29.24%5Y16.62%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity30.82-0.25(-0.81%)NAV As on 20 Dec, 202428-Dec-2015Inception Date1,213.92AUM In Cr.42.34%1Y22.74%3Y27.36%5Y13.34%Since Inception
ITI Pharma & Healthcare Fund-Reg(G)Very HighEquity17.04-0.20(-1.18%)NAV As on 20 Dec, 202408-Nov-2021Inception Date217.92AUM In Cr.44.94%1Y20.89%3YNA%5Y18.64%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors